The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
Open accessAbstract
Treating neutropenic fever with broad-spectrum antibiotics after allogeneic hematopoietic stem cell transplant is associated with an increase in graft-versus-host disease in mice and humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Each of these outcomes, as well as overall survival, has been associated in single-center studies with features of the intestinal microbiota in the period after hematopoietic-cell transplantation.2–4,8–15”
From Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation (2020) · cites this paper as [10]
In the citing paper
“and exposure to certain antibiotic agents at specific times is associated with transplantation-related mortality and GVHD-related mortality.10,16”
From Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation (2020) · cites this paper as [10]
In the citing paper
“Preclinical models have shown that commensal bacteria influence the pathophysiology of GVHD.10,17–20”
From Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation (2020) · cites this paper as [10]
In the citing paper
“Conversely, depletion of gut microbes by broad-spectrum antibiotics prior to T cell therapy can reduce ICB efficacy9 or increase GVHD-related mortality10.”
From A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy (2023) · cites this paper as [10]
In the citing paper
“These antibiotics exert a considerable broad-spectrum, anti-pseudomonal activity, and are also known to severely disrupt the gut microbiome by targeting many anaerobic commensals10,26.”
From A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy (2023) · cites this paper as [10]
In the citing paper
“Dysbiosis and impaired systemic immunity is fairly common in these patients, as they are often treated with concurrent therapies that significantly alter immunity and composition of the gut microbiota”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Shono et al., 2016
In the citing paper
“The gut microbiota may also be impacted by antibiotic treatment for infectious complications during HSCT, with differences in GVHD-associated mortality with different antibiotic regimens”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Shono et al., 2016
In the citing paper
“more recent studies demonstrating detrimental effects of antibiotic use with higher rates of GVHD”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Shono et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 20,145
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Kraken: ultrafast metagenomic sequence classification using exact alignments
Wood, D. E., & Salzberg, S. L. (2014) · Genome Biology · doi:10.1186/gb-2014-15-3-r46 · Cited by 4,521
Cited by
Sorted by citations
Items 401–500 of 592
Young, S. M., Woode, R. A., Williams, E., Ericsson, A. C., & Clarke, L. L. (2023) · Physiological Genomics · doi:10.1152/physiolgenomics.00077.2023 · Cited by 5
Neutrophils Plasticity: The Regulatory Interface in Various Pathological Conditions
Perobelli, S. M., Silva, T. G., & Bonomo, A. (2017) · InTech eBooks · doi:10.5772/68130 · Cited by 5
Self-citationKoyama, D., Murata, M., Hanajiri, R., Okuno, S., Kamoshita, S., Julamanee, J., Takagi, E., Hirano, D., Miyao, K., Sakemura, R. L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185213 · Cited by 5
Ringdén, O. T. H., Remberger, M., Törlén, J., Finnbogadottir, S., Svahn, B., & Sadeghi, B. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03087-w · Cited by 5
Kumari, M., & Kokkiligadda, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00004-6 · Cited by 5
Gut microbiota alteration during allogeneic haematopoietic cell transplantation: what can we do?
Malard, F., & Mohty, M. (2019) · British Journal of Haematology · doi:10.1111/bjh.16204 · Cited by 5
Lee, Y., Seong, J., Lee, J. A., Ahn, J. Y., Jeong, S. J., Ku, N. S., Choi, J., Yeom, J., & Kim, J. H. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaf254 · Cited by 4
Franklin, S., Ramont, C., Batool, M., McMahon, S., Sahasrabhojane, P. V., Blazier, J. C., Kontoyiannis, D. P., Ni, Y., & Galloway-Peña, J. (2025) · Antibiotics · doi:10.3390/antibiotics14080770 · Cited by 4
McMahon, S., Franklin, S., & Galloway-Peña, J. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1629422 · Cited by 7
Godefroy, E., & Altare, F. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102676 · Cited by 4
Millick, D. D., Ghosh, S., Wu, G. G., Krzyzanowska, A. K., Osorio, L., Zhao, L., STRAIR, R. K., & Sant’Angelo, D. B. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024014831 · Cited by 4
Microbiotoxicity: an under-recognised player in drug efficacy, toxicity, and health outcomes
Nascimento, S. S., Theodosiou, A. A., & Sergaki, C. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00165-5 · Cited by 4
Microbiome, GvHD, and immune reconstitution in allogeneic hematopoietic cell transplantation
Weber, D., Tariq, M., Hazenberg, M. D., Poeck, H., & Malard, F. (2026) · Bone Marrow Transplantation · doi:10.1038/s41409-026-02798-0 · Cited by 7
Self-citationTverdek, F. P., Escobar, Z. K., Liu, C., Jain, R., & Lindsay, J. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14129 · Cited by 4
Self-citationBu, X., Pan, W., Wang, J., Liu, L., Yin, Z., Jin, H., Liu, Q., Zheng, L., Sun, H., Gao, Y., et al. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s420747 · Cited by 4
Improving bench-to-bedside translation for acute graft-versus-host disease models
Mims, B. M., Furr, K. L., Enriquez, J., & Grisham, M. B. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052084 · Cited by 4
Toenges, R., Lang, F., Ghaffar, R., Lindner, S., Schlipfenbacher, V., Riemann, J., Ajib, S., Kouidri, K., Cremer, A., Bodo, W., et al. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05986-4 · Cited by 4
Mullish, B. H., Innes, A. J., Roberts, L. A., Anim-Burton, S., Webber, L., Johnson, N. A., Ghani, R., Farshi, P., Khan, A. B., Kinsella, F. A. M., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-093120 · Cited by 6
Newly found arsons ignite the fire of gut GVHD
Zeng, D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98685 · Cited by 4
Hermann, A., Winkler, A., Paschen, C., Kuzmina, Z. J., Hladik, A., Icme, S., & Robak, O. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.05.001 · Cited by 4
Jahan, D., Peile, E., Sheikh, M. A., Islam, S., Parasnath, S., Sharma, P., Iskandar, K., Dhingra, S., Charan, J., Hardcastle, T. C., et al. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1902304 · Cited by 4
Ma, J., Chen, T., Ma, X., Zhang, B., Zhang, J., Xu, L., Wang, Y., Huang, J., Liu, Z., Wang, F., et al. (2022) · BioMedical Engineering OnLine · doi:10.1186/s12938-022-01046-y · Cited by 4
The intestinal microbiota and cellular therapy: implications for impact and mechanisms
Xie, J., & Smith, M. M. (2024) · Blood · doi:10.1182/blood.2024024219 · Cited by 4
Microbiote intestinal et allogreffe de cellules souches hématopoïétiques
Dougé, A., Bay, J., Ravinet, A., & Scanzi, J. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2019.08.014 · Cited by 4
Engaging Cell and Gene Therapists in HIV Cure
Johnston, R. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.236 · Cited by 4
Infektiologie – ein Schwerpunkt der Inneren Medizin
Fätkenheuer, G., Jung, N., Kern, W. V., Fölsch, U. R., & Salzberger, B. (2018) · Der Internist · doi:10.1007/s00108-018-0387-4 · Cited by 4
Peto, L., Fawcett, N., Kamfose, M. M., Scarborough, C., Peniket, A., Danby, R., Peto, T., Crook, D. W., Llewelyn, M., & Walker, A. S. (2024) · eLife · doi:10.7554/elife.97751.1 · Cited by 3
Interleukin Networks in GVHD: Mechanistic Crosstalk, Therapeutic Targeting, and Emerging Paradigms
Niu, Y., Liu, C., Li, P., Zhao, J., Jin, J., & Yang, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178620 · Cited by 3
Self-citationChorão, P., Tejido, S. D. C., Muñoz-Brell, P., Marco, M., Granados, P., González, E. M., Villalba, M., Cantó, P. A., Balaguer‐Roselló, A., Gómez, M. D., et al. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.09.019 · Cited by 4
Consensus guidelines for antibacterial prophylaxis in patients with neutropenia
Lindsay, J., Yeoh, D. K., Teh, B. W., Reynolds, G. K., Henden, A. S., McQuilten, Z., Wheeler, M., Hamilton, A., Nelson, A. C., Nakagaki, M., et al. (2025) · Internal Medicine Journal · doi:10.1111/imj.70250 · Cited by 3
Fan, C., Hayase, T., Chang, C., Glover, I. K., Flores, I. I., McDaniel, L. K., Ortega, M. R., Sanchez, C. A., El-Himri, R. K., Brown, A. N., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025016780 · Cited by 3
Self-citationFarhan, S., Mazur, I., Hartzell, S., Xie, P., Neme, K., German, A. M., Mikulandric, N., Patel, K., Wu, M., Kortam, N., et al. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.107172 · Cited by 3
Nakagaki, M., Hajkowicz, K. M., Roberts, J. A., & Henden, A. S. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2527970 · Cited by 3
Food for Gut: Microbiota Fuels Immune Reconstitution after BMT
Simms-Waldrip, T. R., & Koh, A. Y. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.03.015 · Cited by 3
Drug repurposing in leukemia treatment and hematopoietic stem cell transplantation
Чухловин, А. Б. (2019) · Cellular Therapy and Transplantation · doi:10.18620/ctt-1866-8836-2019-8-1-12-19 · Cited by 3
Gijsen, M., Maertens, J. A., Lagrou, K., Peetermans, W. E., Fage, D., Debaveye, Y. A., & Spriet, I. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.015 · Cited by 3
From Microbes to Immunity: A Comprehensive Review of Microbiome Modulation
Shahid, A., Fatima, M., Khan, M. S. I., Ali, U., Fareed, S. Z., & Qureshi, M. A. (2023) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v3i2.238 · Cited by 3
Hong, Y., Liu, L., Chang, Y., Wang, Y., Zhang, X., Xu, L., Huang, X., & Zhao, X. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-0842-4 · Cited by 3
Biology of Graft-Versus-Host Disease
Novitzky‐Basso, I., & Viswabandya, A. (2020) · Organ and tissue transplantation · doi:10.1007/978-3-319-64938-2_35-1 · Cited by 3
Yan, J., Liao, C., Taylor, B. P., Fontana, E., Amoretti, L. A., Wright, R. J., Dai, A., Waters, N. R., Peled, J. U., Taur, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.23.457365 · Cited by 3
Self-citationAndermann, T. M., Brown, D., Holowka, T., Bartelt, L. A., Serody, J. S., Armistead, P. M., Jamieson, K. J., Conlon, B. P., Rao, G. G., Alby, K., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae760 · Cited by 3
Han, J., Lee, D., Jeong, S., Yun, J., Kang, S., Jang, S., Lee, E., Baek, J. H., Jeon, C. O., & Bae, J. (2025) · Advanced Science · doi:10.1002/advs.202415982 · Cited by 3
Peto, L., Fawcett, N., Kamfose, M. M., Scarborough, C., Peniket, A., Danby, R., Peto, T., Crook, D. W., Llewelyn, M., & Walker, A. S. (2025) · eLife · doi:10.7554/elife.97751.3 · Cited by 3
Akkermansia muciniphila Selectively Reshapes Small Intestinal Cell Populations
Edens-Valentine, R., Engevik, K. A., Engevik, M. A., & Engevik, A. C. (2026) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554261417734 · Cited by 2
Moses, A. B., & Yeh, A. C. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2631224 · Cited by 2
The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation
Hao, W., Stocker, N., Gaugler, B., Mohty, M., & Malard, F. (2026) · American Journal of Hematology · doi:10.1002/ajh.70360 · Cited by 2
Messages from the seventh international conference on clinical metagenomics (ICCMg7)
de Lorenzi-Tognon, M., Ruppé, É., & Schrenzel, J. (2023) · Microbes and Infection · doi:10.1016/j.micinf.2023.105105 · Cited by 2
Microbiome therapeutics for the cancer management
Punetha, A., & Punetha, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00012-4 · Cited by 2
Hein, D., Coughlin, L. A., Poulides, N. A., Koh, A. Y., & Sanford, N. N. (2024) · Journal of Immunotherapy and Precision Oncology · doi:10.36401/jipo-23-30 · Cited by 2
Wenger, V., & Zeiser, R. (2024) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2024.101567 · Cited by 2
Nguyen, A., Fender, J., Courjon, J., Fischer, A., Mappoura, M., Morin, S., Giannotti, F., Mamez, A., Chalandon, Y., Masouridi‐Levrat, S., et al. (2024) · Transplant Infectious Disease · doi:10.1111/tid.14375 · Cited by 2
Exploring the Influence of Oral and Gut Microbiota on Ulcerative Mucositis: A Pilot Cohort Study
Bartha, V., Boutin, S., Schüßler, D. L., Felten, A., Fazeli, S., Kosely, F., Luft, T., Wolff, D., Frese, C., & Schoilew, K. (2025) · Oral Diseases · doi:10.1111/odi.15246 · Cited by 5
Ito, H., Okamura, Y., Tomura, Y., Oshida, J., Fujita, M., & Kobayashi, D. (2025) · Transplant Infectious Disease · doi:10.1111/tid.70049 · Cited by 2
Antimicrobial stewardship in immunocompromised hosts
Wolf, J., Gerber, J. S., & Smith, M. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64198-2.00020-8 · Cited by 2
Microbiome and Diseases: Graft-Versus-Host Disease
Weber, D., & Holler, E. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_13 · Cited by 2
An infectious diseases perspective on the microbiome and allogeneic stem cell transplant
Smibert, O. C., Trubiano, J. A., Slavin, M. A., & Kwong, J. C. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000683 · Cited by 2
Deresinski, S. C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy023 · Cited by 2
Fecal Transplantation in Hematopoietic Transplantation
Peled, J. U., & van den Brink, M. R. M. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01169 · Cited by 2
Self-citationTargeting RIG-I or STING promotes epithelial regeneration
Fischer, J. C., & Poeck, H. (2017) · Oncotarget · doi:10.18632/oncotarget.22994 · Cited by 2
Self-citationGVHD prevention by personalized nutrition
Stein‐Thoeringer, C. K. (2022) · Blood · doi:10.1182/blood.2022017857 · Cited by 2
Distance-Based Analysis with Quantile Regression Models
Li, S., Sun, Y., Diao, L., & Wang, X. (2021) · Statistics in Biosciences · doi:10.1007/s12561-021-09306-6 · Cited by 1
Review: Levofloxacin Prophylaxis in Pediatric Oncology Patients
Scheuermann, A., Huppler, A. R., Mitchell, M. L., & Green, J. S. (2022) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-022-00251-0 · Cited by 1
Zhao, A. T., Holtzman, N. G., Golubić, M., & Pavletic, S. Z. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2024.05.023 · Cited by 1
Research trends and hotspots of osteoporosis and intestinal microbiota: A bibliometric analysis
Zhang, H., Dong, Z., Su, J., Zhou, Z., Li, W., Yuan, X., Chen, L., & Wenquan, H. (2025) · Medicine · doi:10.1097/md.0000000000041939 · Cited by 1
Arjmand, B., Badamchizadeh, S., Mehran, P., Sarvari, M., Alavi-Moghadam, S., Arjmand, R., Rezaei–Tavirani, M., Janbabaei, G., Vaezi, M., & Larijani, B. A. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10958-w · Cited by 1
Probiotics and the immune landscape: An ally in breast cancer combination therapy
Tokallou, M. A., Mahmoudi, M., Kheder, R. K., Azghadi, S. F., Rastgoo, E., Sabouri, A., & Esmaeili, S. (2025) · Nutrition · doi:10.1016/j.nut.2025.113011 · Cited by 1
Li, M., Yuan, F., Li, G., Fu, Y., & Wei, X. (2025) · Cytotherapy · doi:10.1016/j.jcyt.2025.102043 · Cited by 2
Recent advances in the pathophysiology of acute and chronic graft-versus-host disease
Takahashi, S., & Hashimoto, D. (2026) · International Journal of Hematology · doi:10.1007/s12185-026-04177-3 · Cited by 1
The intestinal microbiota as a key modulator of acute graft-versus-host disease
Paredes, J. E., Schmiester, M., Jenq, R. R., & van den Brink, M. R. M. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00910-6 · Cited by 2
Self-citationLiu, S., Huang, Z., & Guo, Z. (2026) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2026.04.016 · Cited by 1
Managing multidrug resistant Gram-negative bacteraemia in immunocompromised hosts
Bonazzetti, C., Toschi, A., & Giannella, M. (2026) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001205 · Cited by 1
Retinoic acid–driven expansion of CD16hiCD177+ neutrophils mediates steroid-resistant GI-GVHD
Liang, W., Xu, D., Zhang, L. F., Qu, Y., Li, L., Zhong, K., Meng, Y., Zhu, J., Wang, S., Tan, L., et al. (2026) · Blood · doi:10.1182/blood.2025032193 · Cited by 1
Armstrong, E., Pinto, R. L., Kulikova, M., Yee, N., Rishu, A., Muscedere, J., Sibley, S. R., Maslove, D. M., Boyd, J. G., Evans, G. A., et al. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag460 · Cited by 1
Paeoniflorin prevents acute graft-versus-host disease while preserving graft-versus-tumor effects
Wan, X., Li, N., Gou, Y., Yang, W., Wu, S., Zhang, J., Liu, S., & Zhang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1937379 · Cited by 1
Sugar-rich foods exacerbate antibiotic-induced microbiome disruption
Dai, A., Ballweg, A., Jogia, W., Rangesa, M., Adintori, P. A., Baichoo, M., Funnell, T., Fei, T., Waters, N. R., Swartz, A., et al. (2026) · Nature · doi:10.1038/s41586-026-11077-3 · Cited by 8
Self-citationFit for cure? Microbiota and GVHD
Holler, E., & Weber, D. (2016) · Blood · doi:10.1182/blood-2016-08-732156 · Cited by 1
Influence of Gastrointestinal Flora in the Treatment of Cancer with Immune Checkpoint Inhibitors
Mendoza, L. (2018) · Klinicka onkologie · doi:10.14735/amko2018465 · Cited by 1
[Advances in intestinal microbiota and graft versus host disease].
Lyu, M., & Han, M. (2017) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2017.12.019 · Cited by 1
Nabarrete, J. M., Pereira, A. Z., Garófolo, A., Seber, A., Venâncio, Â., Grecco, C. E. S., Bonfim, C., Nakamura, C. H., Fernandes, D., Campos, D. J., et al. (2021) · Einstein (São Paulo) · Cited by 1
Parta, M., Cuellar‐Rodríguez, J., Gea‐Banacloche, J., Qin, J., Kelly, C., Zerbe, C. S., Holland, S. M., Malech, H. L., & Kang, E. M. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13815 · Cited by 1
Tang, X., & Wu, D. P. (2022) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2022.05.003 · Cited by 1
Toward Optimizing the Microbiome for Transplant Patients
Markey, K. A. (2022) · The Hematologist · doi:10.1182/hem.v19.5.2022512 · Cited by 1
The inflammasome in graft-versus-host disease
Hamarsheh, S., & Zeiser, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00005-0 · Cited by 1
New insights about immune populations in gastrointestinal GvHD
Hayase, E., & Jenq, R. R. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101126 · Cited by 1
Self-citationBelmont, A. P., Stone, C. A., Guyer, A. C., Edelman, E. J., & Trubiano, J. A. (2024) · Transplant Infectious Disease · doi:10.1111/tid.14350 · Cited by 1
Okinaka, K., Tanaka, T., Ito, A., Fuji, S., Inamoto, Y., Kurosawa, S., Kim, S., & Fukuda, T. (2017) · Journal of Hematopoietic Cell Transplantation · doi:10.7889/hct.6.52 · Cited by 1
Antimicrobial Stewardship in the Hematopoietic Stem Cell Transplant Population
Sexton, M. E., Langston, A. A., Wiley, Z., Nowak, M. D., & Jacob, J. T. (2018) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-018-0159-7 · Cited by 1
Kolb Consulting UG, M., Kolb, H., Weber, D., Simões, B. P., & Holler, E. (2018) · Cellular Therapy and Transplantation · doi:10.18620/ctt-1866-8836-2018-7-1-8-17 · Cited by 1
The impact of microbiota on hematological disorders
Meowad, N. (2017) · Egyptian Journal of Hematology and Bone Marrow Transplantation · doi:10.21608/ejhbmt.2017.19694 · Cited by 1
Antimicrobial Stewardship for Transplant Candidates and Recipients
Liu, C., & Stohs, E. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_6-1 · Cited by 1
Self-citationCzyźewski, K., Salamonowicz, M., Frączkiewicz, J., Zając‐Spychała, O., Goździk, J., Zaucha‐Prażmo, A., & Styczyński, J. (2020) · Acta Haematologica Polonica · doi:10.2478/ahp-2020-0033 · Cited by 1
Andrew, E. C., Khaw, S. L., Hanna, D. T., Conyers, R. K., Fleming, J., Hughes, D., Toro, C., Wang, S. S., Weerdenburg, H., Anderson, S., et al. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14018 · Cited by 1
Antin, J. H. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.2603 · Cited by 1
Ingham, A. C., Kielsen, K., Cilieborg, M. S., Lund, O., Holmes, S., Aarestrup, F. M., Müller, K., & Pamp, S. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/590893 · Cited by 1
Targeting the gut microbiome in allogeneic hematopoietic stem cell transplantationPreprint
de Leeuw, M. A., & Duval, M. X. (2020) · medRxiv · doi:10.1101/2020.04.08.20058198 · Cited by 1
Wang, Y., Morishima, T., Sezaki, M., Nakato, G., Fukuda, S., Li, Y., & Takizawa, H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.03.474846 · Cited by 1
A gut-graft axis mediated by microbiota
Bejanyan, N., & Rashidi, A. (2022) · Blood · doi:10.1182/blood.2021015338 · Cited by 1
Biology of Graft-Versus-Host Disease
Novitzky‐Basso, I., & Viswabandya, A. (2021) · Organ and tissue transplantation · doi:10.1007/978-3-030-36358-1_35 · Cited by 1
Ingham, A. C., Kielsen, K., Mordhorst, H., Ifversen, M., Aarestrup, F. M., Müller, K., & Pamp, S. J. (2021) · Research Square · doi:10.21203/rs.3.rs-258775/v1 · Cited by 1
Hsu, L., Rosenbaum, J. T., Lindner, S., Allanore, Y., Cauvet, A., Pawar, R. D., Li, D., van den Brink, M. R. M., & Miller, R. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.27.564296 · Cited by 1
Metadata
- Authors
- Shono, Y., Docampo, M. D., Peled, J. U., Perobelli, S. M., Velardi, E., Tsai, J. J., Slingerland, A. E., Smith, O. M., Young, L. F., Gupta, J., Lieberman, S. R., Jay, H. V., Ahr, K. F., Porosnicu Rodriguez, K. A., Xu, K., Calarfiore, M., Poeck, H., Caballero, S., Devlin, S. M., Rapaport, F., Dudakov, J. A., Hanash, A. M., Gyurkocza, B., Murphy, G. F., Gomes, C., Liu, C., Moss, E. L., Falconer, S. B., Bhatt, A. S., Taur, Y., Pamer, E. G., van den Brink, M. R. M., & Jenq, R. R.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Department of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- Program in Dermatopathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Brigham and Women's Hospital (US)
- Rutgers, The State University of New Jersey (US)
- Stanford University (US)
- Corresponding author
- Shono, Yusuke
- Jenq, Robert R.
- ORCID
- Shono, Yusuke
- Docampo, Melissa D.
- Peled, Jonathan U.
- Perobelli, Suelen M.
- Velardi, Enrico
- Tsai, Jennifer J.
- Slingerland, Ann E.
- Young, Lauren F.
- Lieberman, Sophia R.
- Ahr, Katya F.
- Xu, Ke
- Poeck, Hendrik
- Devlin, Sean M.
- Dudakov, Jarrod A.
- Hanash, Alan M.
- Gyurkocza, Boglarka
- Gomes, Camilla
- Liu, Chen
- Bhatt, Ami S.
- Taur, Ying
- Pamer, Eric G.
- Jenq, Robert R.
- Venue
- Science Translational Medicine
- Published
- 2016-05-18
- Volume
- 8
- Issue
- 339
- Pages
- 339ra71-339ra71
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC4991773
- OpenAlex
- W2407774696
- Cited by
- 592
- References
- 78
- Citations by year
- 2026: 49 · 2025: 70 · 2024: 47 · 2023: 61 · 2022: 58 · 2021: 81 · 2020: 65 · 2019: 50 · 2018: 50 · 2017: 47 · 2016: 14
- FWCI
- 51.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- NIH (R01-HL069929, R01-AI100288, R01-AI080455, R01-AI101406, R00-CA176376, R01-HL124112)
- Radiation Effects Research Foundation_National Institute of Allergy and Infectious Diseases
- American Society for Blood and Marrow Transplantation
- Australian National Health
- Medical Research Council
- American Society of Hematology
- DKMS (German Bone Marrow Donor Center) Foundation for Giving Life
- Lymphoma Foundation
- NCI (P30-CA008748)
- NIH Cancer Center Support (P30 CA008748-48)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- graft-versus-host disease, allogeneic hematopoietic stem cell transplantation, broad-spectrum antibiotics, imipenem/cilastatin, piperacillin-tazobactam, aztreonam, cefepime, febrile neutropenia, gut microbiota, Akkermansia muciniphila, intestinal mucus barrier, intestinal barrier function, short-chain fatty acids, regulatory T cells
- MeSH terms
- Gastrointestinal Microbiome, Piperacillin, Tazobactam Drug Combination, Cilastatin, Imipenem Drug Combination, Animals, Anti-Bacterial Agents, Colon, Drug Combinations, Feces, Female, Flow Cytometry, Graft vs Host Disease, Humans, Mice, Inbred C57BL, Penicillanic Acid, Phylogeny, Piperacillin, Transplantation, Homologous, Cilastatin, Imipenem, CD4-Positive T-Lymphocytes, Hematopoietic Stem Cell Transplantation, Mice, Interleukin-23, Verrucomicrobia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
